See more : Farmers & Merchants Bancorp, Inc. (FMAO) Income Statement Analysis – Financial Results
Complete financial analysis of Resverlogix Corp. (RVX.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Resverlogix Corp., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Jatcorp Limited (JAT.AX) Income Statement Analysis – Financial Results
- People’s United Financial, Inc. (0KH6.L) Income Statement Analysis – Financial Results
- Keshun Waterproof Technology Co.,Ltd. (300737.SZ) Income Statement Analysis – Financial Results
- TrackX Holdings Inc. (TKX.V) Income Statement Analysis – Financial Results
- Norsk Hydro ASA (NHY.OL) Income Statement Analysis – Financial Results
Resverlogix Corp. (RVX.TO)
About Resverlogix Corp.
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 82.88K | 2.80K | 138.17K | 0.00 | 289.95K | 243.64K | 175.06K | 17.59K | 0.00 | 5.90K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 82.88K | 2.80K | 138.17K | 0.00 | 289.95K | 243.64K | 175.06K | 17.59K | 0.00 | 5.90K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 100.00% |
| Research & Development | 5.51M | 4.52M | 6.40K | 15.80M | 32.34K | 37.79M | 29.88M | 15.68M | -4.19M | -9.81M | -28.43M | 19.74M | 14.42M | 15.11M | 11.40M | 14.60M | 9.57M | 3.03M | 1.25M | 263.92K | 194.13K | 0.00 |
| General & Administrative | 6.94M | 11.12M | 0.00 | 6.78M | 6.51K | 4.07M | 4.27M | 4.33M | -4.27M | -4.23M | -6.21M | 0.00 | 7.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 45.08K |
| Selling & Marketing | 0.00 | 6.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.94M | 11.12M | 8.28K | 6.78M | 6.51K | 4.07M | 4.27M | 4.33M | -4.27M | -4.23M | -6.21M | 5.27M | 7.52M | 6.74M | 5.11M | 9.76M | 6.09M | 3.35M | 1.68M | 1.04M | 296.08K | 45.08K |
| Other Expenses | 264.00K | 212.00K | 0.00 | 91.60M | 0.00 | -11.30M | -8.50M | -6.40M | -6.20M | -13.65M | 0.00 | -383.00K | 272.54K | 4.19M | 1.21M | 457.24K | 519.60K | 214.28K | 114.89K | 106.06K | 22.62K | 0.00 |
| Operating Expenses | 12.71M | 15.85M | 4.45K | 22.58M | 157.81K | 41.86M | 34.14M | 20.01M | -8.46M | -14.04M | -34.64M | 24.63M | 22.20M | 22.08M | 17.73M | 24.82M | 16.18M | 6.59M | 3.05M | 1.41M | 512.83K | 45.08K |
| Cost & Expenses | 12.71M | 15.85M | 4.45K | 22.58M | 157.81K | 41.86M | 34.14M | 20.01M | -8.46M | -14.04M | -34.64M | 24.63M | 22.20M | 22.08M | 17.73M | 24.82M | 16.18M | 6.59M | 3.05M | 1.41M | 512.83K | 45.08K |
| Interest Income | 0.00 | 0.00 | 1.95K | 0.00 | 4.96K | 0.00 | 7.03M | 6.19M | 5.82M | 3.71M | 1.69M | 71.00 | 82.88K | 2.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.63M | 727.00K | 0.00 | 3.57M | 5.63M | 5.45M | 7.03M | 6.19M | 5.82M | 3.71M | 0.00 | 0.00 | 0.00 | 1.20M | 2.09M | -167.16K | 0.00 | 32.27K | 0.00 | 20.49K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.01M | 1.11M | 369.00 | 1.03M | 328.00 | 358.00K | 377.00K | 284.00K | 212.00K | 89.00K | 247.00K | 583.00K | 302.58K | 239.99K | 220.48K | 457.24K | 348.76K | 214.28K | 114.89K | 106.06K | 22.62K | 0.00 |
| EBITDA | -11.74M | -14.87M | -14.20K | -74.15M | -38.41K | -30.54M | -28.82M | -26.22M | 3.54M | 73.41M | 26.25M | -24.18M | -21.82M | -21.84M | -18.95M | -24.36M | -15.37M | -6.14M | -2.76M | -1.28M | -490.21K | -39.18K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -26,326.67% | -778,964.12% | -13,711.86% | 0.00% | -5,299.54% | -2,518.92% | -1,574.34% | -7,300.84% | 0.00% | -663.84% |
| Operating Income | -12.75M | -15.97M | -14.57K | -22.58M | -38.74K | -30.90M | -34.14M | -20.01M | -8.46M | -14.04M | -34.64M | -24.76M | -22.12M | -22.08M | -19.17M | -24.82M | -15.89M | -6.35M | -2.87M | -1.39M | -512.83K | -39.18K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -26,691.77% | -787,524.33% | -13,871.44% | 0.00% | -5,478.74% | -2,606.87% | -1,639.97% | -7,903.73% | 0.00% | -663.84% |
| Total Other Income/Expenses | 9.16M | -8.79M | 17.07K | 144.20M | -124.03K | -10.96M | -4.95M | 6.49M | 5.13M | -72.93M | 8.63M | 136.00K | 0.00 | 4.19M | 1.58M | 167.16K | 159.56K | -32.27K | 33.58K | -20.49K | 0.00 | 0.00 |
| Income Before Tax | -3.59M | -24.76M | 2.50K | 118.05M | -162.77K | -58.26M | -46.13M | -19.70M | 19.41M | -55.19M | 44.95M | -18.67M | 0.00 | -17.89M | -17.59M | -24.65M | -15.73M | -6.38M | -2.84M | -1.41M | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -638,108.35% | -12,730.74% | 0.00% | -5,423.71% | -2,620.11% | -1,620.79% | -8,020.21% | 0.00% | 0.00% |
| Income Tax Expense | 18.00K | 12.00K | 31.50 | 27.00K | 29.00 | 47.00K | 83.00K | 11.00K | 1.09M | -82.00K | 1.60M | 117.00K | 0.00 | 4.19M | -3.15M | 3.31M | 832.98K | 32.27K | -33.58K | 20.49K | 0.00 | 39.18K |
| Net Income | -3.61M | -24.77M | 2.46K | 118.03M | -162.80K | -58.31M | -46.21M | -19.72M | 18.32M | -55.10M | 43.36M | -18.78M | -22.12M | -27.47M | -18.10M | -28.13M | -16.55M | -6.38M | -2.84M | -1.41M | -512.83K | -39.18K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -26,691.77% | -979,683.80% | -13,101.81% | 0.00% | -5,707.10% | -2,620.11% | -1,620.79% | -8,020.21% | 0.00% | -663.84% |
| EPS | -0.01 | -0.10 | 0.01 | 0.57 | -0.87 | -0.42 | -0.44 | -0.20 | -0.22 | -0.69 | 0.58 | -0.29 | -0.43 | -0.67 | -0.61 | -1.09 | -0.69 | -0.27 | -0.14 | -0.09 | -0.05 | 0.00 |
| EPS Diluted | -0.01 | -0.10 | 0.01 | 0.54 | -0.87 | -0.42 | -0.44 | -0.20 | -0.22 | -0.69 | 0.58 | -0.29 | -0.42 | -0.67 | -0.61 | -1.09 | -0.69 | -0.27 | -0.14 | -0.09 | -0.05 | 0.00 |
| Weighted Avg Shares Out | 254.42M | 239.87M | 220.34K | 208.25M | 187.12K | 137.74M | 105.35M | 100.98M | 85.08M | 79.50M | 74.22M | 64.62M | 51.35M | 41.10M | 29.64M | 25.84M | 24.10M | 23.82M | 20.56M | 16.06M | 10.73M | 9.42M |
| Weighted Avg Shares Out (Dil) | 254.42M | 239.87M | 231.85K | 221.43M | 188.10K | 137.74M | 105.35M | 100.98M | 85.08M | 79.50M | 74.22M | 64.62M | 52.21M | 41.10M | 29.64M | 25.84M | 24.10M | 23.82M | 20.56M | 16.06M | 10.73M | 9.42M |
No news found for: RVX.TO
Source: https://incomestatements.info
Category: Stock Reports